Key result
Home BP telemonitoring in high-risk pregnancies is linked to ~20% fewer composite adverse outcomes.
Why the study?
To evaluate patient experiences, usability, and patient-centeredness with the SAFE@home platform for BP telemonitoring and symptom tracking in high-risk pregnancies, identifying barriers and facilitators for digital health scale-up.
Does daily home telemonitoring of blood pressure and symptoms improve patient-reported usability and client-centeredness in patients with high-risk pregnancies compared to usual care?
Cohort (n=606)
Yes
Does daily home telemonitoring of blood pressure and symptoms improve patient-reported usability and client-centeredness in patients with high-risk pregnancies compared to usual care?
Blood pressure telemonitoring in high-risk pregnancies demonstrates high patient acceptability and usability, supporting its feasibility as a scalable model for digital obstetric care.
Answers are grounded in this paper and cite their sources.
High usability supports feasibility of telemonitoring in high-risk pregnancies; leaves open efficacy confirmation in randomized trials.
OBJECTIVE: This study evaluates patient experiences with the SAFE@home platform for telemonitoring of blood pressure (BP) and symptom tracking in patients high-risk pregnancies. We hypothesized patients would perceive telemonitoring as usable and patient-centered and aimed to identify barriers and facilitators to aid future digital health scale-up. METHODS: A quantitative analysis within a cohort study across 11 hospitals was conducted. Patients with a high risk of or established HDP home monitored their BP and symptoms daily via the SAFE@home platform. The SAFE@home group had less composite adverse outcomes (17.2 % vs. 21.5) compared to the usual care group. The patient satisfaction and perceived quality of care (PSPQC) questionnaire and client centered care questionnaire (CCCQ) were answered on a 5-point Likert-scale. Primary outcomes were usability and client-centeredness, with ≥ 20 % disagreement indicating barriers and ≥ 80 % agreement indicating facilitators. RESULTS: Of the 606 participants, 376 (62%) completed the survey. The majority indicated high usability for SAFE@home: 98% found it useful for BP monitoring, and 86-95% rated it easy to use. Around 68% felt more in control, 81% appreciated the alignment with personal preferences and 92% would recommend SAFE@home to others. However, 51% of the patients felt they could independently manage their care and 25% did not know who to contact with technical issues. CONCLUSION: Telemonitoring of BP and symptoms in high-risk pregnancies demonstrates high usability and acceptance among patients, improving engagement and control. While autonomy and technical support require improvement, SAFE@home represents a feasible and scalable model for integrating digital care into obstetrics.
No takes yet. Share an insight, caveat, or question.
Moes et al. (2025) conducted a cohort in High-risk pregnancies (n=606). SAFE@home platform for telemonitoring of blood pressure and symptom tracking vs. Usual care was evaluated on Composite adverse outcomes. Telemonitoring of blood pressure using the SAFE@home platform in high-risk pregnancies was associated with fewer composite adverse outcomes (17.2% vs. 21.5%) and demonstrated high usability.
Synapse has enriched 10 related papers. Consider them for comparative context: